Cureline Baltic UAB, a member of Cureline Group (Translational and Precision Medicine CRO based in California, USA) is exhibiting at BIO-2022 (June 13-16, 2022; San Diego, CA).

If you are interested in outsourcing preclinical projects to be conducted in the EU – please stop by a Lithuanian delegation booth at BIO-2022. Cureline Baltic UAB is expanding to 15+ employees in order to conduct two major research projects funded by the Lithuanian Invest+ grants in 2022 – 2023. Cureline Group is planning to grow operations in the EU and other ex-USA markets by at least 50% during this time.